BioPortfolio - Bone Care International Incorporated - Profile
Bone Care is a leader in the discovery and development of improved vitamin D- hormone therapies for the. treatment of secondary hyperparathyroidism and ...
http://www.bioportfolio.com/biocorporate/2091-Bone%252BCare%...
|
Epidemic of Undiagnosed Secondary Hyperparathyroidism in Early ...
Return to Epidemic of Undiagnosed Secondary Hyperparathyroidism in Early Chronic ... Disclosure: Grants/Research Support: Abbott, Amgen, Baxter, Bone Care ...
http://www.medscape.com/viewprogram/3766_authors...
|
Genzyme and Bone Care International Announce Completion of Hart ...
As announced on May 4, 2005, Genzyme and Bone Care have signed a definitive ... to treat secondary hyperparathyroidism in patients with moderate to severe ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
Managing Secondary Hyperparathyroidism and Bone Mineral ...
Managing Secondary Hyperparathyroidism and Bone Mineral Abnormalities in Patients With ... to Associates in Nephrology, SC and Fresenius Medical Care, NA . ...
http://www.medscape.com/viewprogram/9042...
|
MedlinePlus Medical Encyclopedia: Secondary hyperparathyroidism
20 Oct 2008 ... This is a variable syndrome comprising osteomalacia, osteoporosis, secondary hyperparathyroidism, or osteosclerosis. Bone pain, weakness ...
https://www.nlm.nih.gov/medlineplus/ency/article/000318.htm...
|
Bone Care International Announces Advancement of LR-103 Into Human ...
... use of LR-103 to treat secondary hyperparathyroidism in patients with CKD. ... Contact: Bone Care International, Inc. Brian J. Hayden Chief Financial ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=...
|
New Drugs of 1999
Agent for Secondary Hyperparathyroidism. Antiobesity Agent ... Doxercalciferol ( Hectorol -- Bone Care International) is a synthetic vitamin D analog that is ...
http://www.medscape.com/viewarticle/406681_15...
|
NDA 20-862/S-006 Bone Care International Attention: R. Andrew ...
Bone Care International. Attention: R. Andrew Morgan, R.Ph. ... Capsules, (0.5 ug), for the management of secondary hyperparathyroidism in patients with ...
http://www.fda.gov/cder/foi/appletter/2004/20862se1-006ltr.p...
|
Managing Secondary Hyperparathyroidism and Bone Mineral ...
Return to Managing Secondary Hyperparathyroidism and Bone Mineral ... clinicians who care for populations of patients with secondary hyperparathyroidism and ...
http://www.medscape.com/viewprogram/9042_learning...
|
NDA 21-027 Bone Care International Attention: Ms. Darlene Kyllo ...
Bone Care International. Attention: Ms. Darlene Kyllo ... of elevated iPTH levels in the management of secondary hyperparathyroidism in patients undergoing ...
http://www.fda.gov/cder/foi/appletter/2000/21027ltr.pdf...
|